Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

1.7K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.7K
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

3.6K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.6K
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

3.2K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
3.2K
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

2.2K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
2.2K
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

40
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
40
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

1.2K
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Elevated cfDNA after exercise is derived primarily from mature polymorphonuclear neutrophils, with a minor contribution of cardiomyocytes.

Cell reports. Medicine·2026
Same author

Prehospital management of impending airway obstruction in combat trauma: a registry study.

BMJ military health·2026
Same author

Methodological Considerations for Studies in Sport and Exercise Science with Women as Participants Part II: Guidance for Applied Studies in Elite Female Athletes.

Sports medicine (Auckland, N.Z.)·2026
Same author

A characterisation of elite open water swimmers' core temperature responses and preparation practices in European Aquatics competitions.

Journal of science and medicine in sport·2026
Same author

Coronary Artery Disease in Female Athletes.

JACC. Case reports·2026
Same author

Beyond the classroom: a qualitative study of voluntary home visits to older adults as a tool for empathy and professional growth in medical students.

Medical education online·2025

Related Experiment Video

Updated: Apr 24, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.8K

[Statins and muscle pain].

Yoni Yosef, Daniel Schurr, Naama Constantini

    Harefuah
    |September 6, 2014
    PubMed
    Summary

    Statins can cause muscle pain, but patients should still exercise for cardiovascular benefits. Report any pain, as dose adjustment or discontinuation may be needed.

    Area of Science:

    • Cardiology
    • Pharmacology
    • Exercise Physiology

    Context:

    • Statins are widely prescribed for cardiovascular disease prevention and treatment.
    • Muscle pain is a common side effect, impacting patient adherence to exercise.
    • Exercise and statins offer synergistic benefits for cardiovascular health.

    Purpose:

    • To review the impact of statin-induced muscle pain on exercise.
    • To discuss the prevalence, characteristics, and risk factors of statin-associated muscle symptoms (SAMS).
    • To provide recommendations for managing SAMS in patients undergoing statin therapy.

    Summary:

    • Statin-associated muscle pain affects 1-30% of patients and can occur anytime during treatment.
    • While creatine phosphokinase (CPK) levels may rise, severe muscle damage like rhabdomyolysis is rare.

    Related Experiment Videos

    Last Updated: Apr 24, 2026

    Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
    09:15

    Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

    Published on: November 10, 2017

    14.8K
  • Risk factors include age, comorbidities, and drug interactions; pain usually resolves after discontinuation.

    • Impact:

    • Encouraging exercise in patients taking statins is vital due to combined benefits.
    • Patients must report new or worsening muscle pain for timely intervention.
    • Management strategies include dose reduction, drug switching, or temporary discontinuation to mitigate SAMS and maintain exercise participation.